Walking on the streets of almost any city, we can see that there are quite a bunch of building sites, cranes, and upcoming wonderful colors on the walls of new hospitals enabling more modern...
Recent Posts
Innokas Medical strengthens its QA&RA services with a new Clinical Affairs team. The new team supports medical device companies in carrying out resource-binding clinical evaluation related work by...
In the face of challenging and changing times, experience, expertise, and quality are of great importance. Innokas Medical has a long experience in the field of health technology, but what expertise...
Long-term experience and wide competence pool enable agile co-creation of next generation medical devices together with customers.
The healthcare technology industry is evolving with various global trends. In recent years, one trend has been clear: software and data-driven solutions are revolutionizing the future of patient...
FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, is a clinically promising, patented and cost-efficient home treatment solution for Peripheral Arterial...
It has been noted that the occurrence of use errors, also called as human error, increases the number and severity of incidents related to the use of medical devices. Use errors typically occur when...
Across industries, the pace to introduce new products is increasing. This puts pressure on companies to shorten the design and development cycles. Medical devices are no exception in this respect.
With their next-generation innovation, Synoste aims to renew surgical treatment related to bone deformities. Innokas Medical is involved in this mission by being one of Synoste's co-creation partners...
